| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 5e-08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 3e-06 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |